Galderma

Face Up To Rosacea: Galderma Launches Online Support to Empower and Equip Rosacea Sufferers to Discuss the True Burden of Their Disease With a Dermatologist

Launched today, Galderma's new Face up to rosacea campaign aims to help close the communication gap between people with rosacea and dermatologists.

OTE0001
21.10.2019 11:11
 

#RosaceaNoFilter: Online Influencers Take the Lead in Raising Rosacea Awareness in Galderma's Empowering Rosacea Awareness Month Social Media Campaign

Building on the success of its Rosacea: Beyond the visible disease awareness campaign, Galderma is uniting with top rosacea influencers to launch an empowering social media awareness movement during Rosacea …

OTE0003
15.04.2019 10:01
 

Galderma: Neue Daten zeigen Vorteile einer Kombination aus oraler und topischer Behandlung bei Patienten mit schwerer papulopustulöser Rosazea

Erste randomisierte klinische Studie zum Vergleich der Wirksamkeit und Sicherheit einer Kombination aus 40 mg Doxycyclin mit modifizierter Freisetzung (DMR) und einer Creme mit 1 % Ivermectin (IVM) mit …

OTS0027
02.03.2019 14:08
 

Experten fordern eine verbesserte Identifizierung von Rosacea-Patienten mit hoher Krankheitsbelastung im Praxisalltag

Zusätzliche Analyse globaler Umfragedaten ergibt, dass die Lebensqualität von vielen Faktoren abhängt, nicht nur vom Schweregrad von Rosacea

OTS0048
16.09.2018 18:09
 

Galderma Global Study Reveals True Burden of Rosacea and Encourages Healthcare Professionals to Look 'Beyond the visible'

Galderma today released the findings of a global survey highlighting the need for dermatologists and doctors to proactively open a dialogue with patients about the true burden of rosacea and ways in which …

OTE0007
01.06.2018 12:18
 

Galderma: 'Clear' (IGA 0) Rosacea Patients Experience a Delayed Time to Relapse

Today, the results of a pooled analysis of four Galderma-sponsored studies evaluating the use of topical therapies for the treatment of inflammatory papules and pustules of rosacea were presented at the …

OTE0001
16.09.2017 13:58
 

Galderma: Combined Use of Rosacea Therapies Ivermectin 1% Cream and Brimonidine 0.33% Gel Evaluated in MOSAIC Study

Today, the results of a study evaluating the combined use of topical rosacea treatments ivermectin 1% cream and brimonidine 0.33% gel were published in the Journal of Drugs in Dermatology.

OTE0002
11.09.2017 10:20
 
OTS0147
28.09.2016 13:15
 

SKINPACT Programme Launched Today with New Global Awards Initiative to Support the Dermatology Community

Galderma is proud to announce the launch of a new global initiative under the SKINPACT Programme that will provide support for two new projects in the field of community dermatology.

OTE0002
10.10.2014 07:33
 
OTE0005
26.02.2014 07:03